Locust Walk Insights
LOCUST WALK INSIGHTS
Biopharma Deal Maker’s Guide to Strategic Partnerships: Panel RECORDING
Thank you to all that joined us on Thursday, May 7th for our live panel discussion where we took a deep dive into biopharma deal marker's best practices for strategic partnerships. Listen to the recording. Please stay tuned for more live panels and webinars in the...
Q1 2020 Biopharma Market Conditions Live Panel RECORDING
Thank you to all that joined us on Thursday, April 16th for our live panel discussion where we took a deep dive into Q1 2020 biopharma market conditions, and in particular, how COVID-19 has played a role in the impact. Listen to the recording. Please stay tuned for...
Q1 2020 Report: Global Trends in Biopharma Transactions
Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q1 2020 Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life science deal...
LIVE Panel Discussion: Q1 2020 Biopharma Market Conditions
Please join us Thursday, April 16th from 2-3 pm EST where our team will dive into Q1 2020 market conditions with a lens on partnerships, financings, and insight into current and future trends. We will be releasing our Q1 2020 bipopharma market conditions report in...
COVID-19 Live Panel RECORDING
Thank you to all that joined us on Thursday, April 2nd for our live panel discussion where we took a deep dive into the strategic implications of COVID-19 on biopharma companies and investors. It was a great turnout and thank you for your questions. We weren't able to...
LIVE Panel Discussion, COVID-19: Strategic Implications on Biopharma
Please join us Thursday, April 2nd from 1-2 PM EST to listen to the LIVE panel, COVID 19: Strategic Implications on Biopharma. Following our COVID-19 thought leadership piece on the strategic implications for biopharma, our panelists look forward to taking a deeper...
Strategic Implications of COVID-19 on Biopharma
These are challenging times for governments, public health administrations and the financial markets. While each biopharma company's primary concern is the health and safety of its team members, the industry also a responsibility to the world to take an active role in...
Deal Theory: a Biopharma Deal Maker’s Approach to Maximizing Strategic Partnerships
We are pleased to present this whitepaper to you, Deal Theory: A Biopharma Deal Maker’s Approach to Maximizing Strategic Value, to share some best practices that will help companies achieve better results through the right partnership transactions.
Deal Makers of Japan, Volume 1
Locust Walk has been active in Asia, in particular, Japan for nearly half of the firm’s history and we are deeply rooted in the market. We have advised on more than a dozen transactions during our history in Japan and have successfully helped deal making between US/EU...
2019 Year End Review Biopharma Report
Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our 2019 Annual Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life sciences deal...
2019 Medtech Year End Review Report
Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Medtech 2019 Annual Report: Global Trends in Medtech Transactions applies the latest data to analyze current activities in the medtech deal...
Q3 2019 Report: Global Trends in Medtech Transactions
Every quarter, Locust Walk's medtech team compiles the latest statistics and trends on strategic medtech transactions and financings, with a focus on upcoming trends.
Q3 2019 Global Trends in Biopharma Transactions
At the end of each quarter, our biopharma team here at Locust Walk reviews the global trends in biopharma transactions with an eye on future trends.
Whitepaper Download: Inside Out
Based on recent acquisition activity by two of the largest pharmaceutical companies, it seems as if the historical orthodoxy that great biopharma companies are made from the inside out may be losing validity.
My (National Lampoon’s) European Vacation
I recently returned from a month in Europe as part of our effort to expand Locust Walk's European practice. It was an amazing trip meeting great people and learning valuable lessons. While I did not visit all countries for business, I thought I'd share a...